(Q38002452)

26 August 2017

title

Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation (English)

1 reference

26 August 2017

0 references

1 reference

1 reference

1 reference

4

Russel J Reiter

1 reference

26 August 2017

author name string

Emilio J Sanchez-Barcelo

series ordinal

1

1 reference

26 August 2017

Maria D Mediavilla

series ordinal

2

1 reference

26 August 2017

Carolina Alonso-Gonzalez

series ordinal

3

1 reference

26 August 2017

language of work or name

English

0 references

publication date

16 April 2012

1 reference

Expert Opinion on Investigational Drugs

26 August 2017

published in

1 reference

26 August 2017

volume

21

1 reference

26 August 2017

issue

6

1 reference

26 August 2017

page(s)

819-831

1 reference

Melatonin--a pleiotropic, orchestrating regulator molecule

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Basic mechanisms involved in the anti-cancer effects of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Clinical uses of melatonin: evaluation of human trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Serum melatonin in central precocious puberty is lower than in age-matched prepubertal children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Hypogonadotrophic hypogonadism and primary amenorrhoea associated with increased melatonin secretion from a cystic pineal lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Melatonin stimulates the release of gonadotropin-inhibitory hormone by the avian hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Identification of human GnIH homologs, RFRP-1 and RFRP-3, and the cognate receptor, GPR147 in the human hypothalamic pituitary axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Melatonin-estrogen interactions in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Involvement of the mt1 melatonin receptor in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Functional interactions between calmodulin and estrogen receptor-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Melatonin stimulates calmodulin phosphorylation by protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Melatonin inhibits mitogenic cross-talk between retinoic acid-related orphan receptor alpha (RORalpha) and ERalpha in MCF-7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Melatonin as a selective estrogen enzyme modulator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Role of oxygen free radicals in cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Melatonin as a natural ally against oxidative stress: a physicochemical examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Regulation of antioxidant enzymes: a significant role for melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Anticarcinogenic actions of melatonin which involve antioxidative processes: comparison with other antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Hormonal mechanisms underlying the relationship between obesity and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Effect of family history, obesity and exercise on breast cancer risk among postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Determinants of tissue estradiol levels and biologic responsiveness in breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Estrogen increases in vivo leptin production in rats and human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkappaB/HIF-1alpha activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Oral contraceptive use and breast cancer: a prospective study of young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Light at night, chronodisruption, melatonin suppression, and cancer risk: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Rotating night shifts and risk of breast cancer in women participating in the nurses' health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Global breast cancer seasonality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Exposure to light-at-night increases the growth of DMBA-induced mammary adenocarcinomas in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Preventive therapy for breast cancer: a consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Risk-benefit profile for raloxifene: 4-year data From the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Lasofoxifene in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Melatonin and mammary pathological growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague-Dawley rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Light and exercise and melatonin production in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Blue light from light-emitting diodes elicits a dose-dependent suppression of melatonin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Blue blocker glasses impede the capacity of bright light to suppress melatonin production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Overview of preoperative radiochemotherapy in breast cancer: past or future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

A Radiobiological Review on Melatonin: A Novel Radioprotector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Role of exogenous melatonin in reducing the nephrotoxic effect of daunorubicin and doxorubicin in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Prevention of doxorubicin-induced cardiotoxicity by melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Melatonin-induced gene expression changes and its preventive effects on adriamycin-induced lipid peroxidation in rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

The role of chemotherapy and targeted agents in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Expression of melatonin receptor (MT1) and interaction between melatonin and estrogen in endometrial cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Melatonin, a promising role in taxane-related neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Cis-platinum-induced immunosuppression: relationship to melatonin in human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Melatonin, a pineal secretory product with antioxidant properties, protects against cisplatin-induced nephrotoxicity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Improvement of capecitabine antitumoral activity by melatonin in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Tamoxifen metabolites as active inhibitors of aromatase in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Novel melatonin-based therapies: potential advances in the treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2012.681045

10.1517/13543784.2012.681045

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference